CELU Celularity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CELU

Price (delayed)

$3.29

Market cap

$63.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10.1

Enterprise value

$109.73M

Highlights
CELU's debt is down by 9% year-on-year
The gross margin has dropped by 180% year-on-year but it has increased by 8% since the previous quarter
The gross profit has dropped by 163% year-on-year but it is up by 10% since the previous quarter
The company's net income has shrunk by 119% QoQ
Celularity's EPS has shrunk by 110% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of CELU
Market
Shares outstanding
19.38M
Market cap
$63.75M
Enterprise value
$109.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.08
Price to sales (P/S)
4.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.42
Earnings
Revenue
$14.79M
EBIT
-$179.04M
EBITDA
-$169.66M
Free cash flow
-$65.18M
Per share
EPS
-$10.1
Free cash flow per share
-$3.46
Book value per share
$1.58
Revenue per share
$0.79
TBVPS
$7.34
Balance sheet
Total assets
$157.19M
Total liabilities
$126.95M
Debt
$61.08M
Equity
$30.25M
Working capital
-$68.13M
Liquidity
Debt to equity
2.02
Current ratio
0.19
Quick ratio
0.25
Net debt/EBITDA
-0.27
Margins
EBITDA margin
-1,147.3%
Gross margin
-25%
Net margin
-1,226.7%
Operating margin
-2,334.9%
Efficiency
Return on assets
-62.2%
Return on equity
-144.2%
Return on invested capital
-148%
Return on capital employed
-246.8%
Return on sales
-1,210.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CELU stock price

How has the Celularity stock price performed over time
Intraday
7.52%
1 week
8.94%
1 month
-37.57%
1 year
522.99%
YTD
32.98%
QTD
-37.09%

Financial performance

How have Celularity's revenue and profit performed over time
Revenue
$14.79M
Gross profit
-$3.7M
Operating income
-$345.29M
Net income
-$181.41M
Gross margin
-25%
Net margin
-1,226.7%
Celularity's operating margin has shrunk by 182% YoY and by 24% QoQ
The gross margin has dropped by 180% year-on-year but it has increased by 8% since the previous quarter
The gross profit has dropped by 163% year-on-year but it is up by 10% since the previous quarter
CELU's net margin has dropped by 124% since the previous quarter

Growth

What is Celularity's growth rate over time

Valuation

What is Celularity stock price valuation
P/E
N/A
P/B
2.08
P/S
4.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.42
Celularity's EPS has shrunk by 110% QoQ
The P/B is 108% more than the last 4 quarters average of 1.0
CELU's equity has dropped by 82% year-on-year and by 74% since the previous quarter
CELU's P/S is 73% below its 5-year quarterly average of 15.6 and 33% below its last 4 quarters average of 6.3
CELU's revenue is down by 21% year-on-year and by 2.3% since the previous quarter

Efficiency

How efficient is Celularity business performance
The return on equity has dropped by 178% since the previous quarter
CELU's ROA has dropped by 172% since the previous quarter
CELU's return on invested capital has dropped by 135% since the previous quarter
Celularity's return on sales has shrunk by 125% QoQ

Dividends

What is CELU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CELU.

Financial health

How did Celularity financials performed over time
CELU's total assets is 24% greater than its total liabilities
Celularity's current ratio has shrunk by 79% YoY and by 32% QoQ
The quick ratio has dropped by 74% year-on-year and by 29% since the previous quarter
CELU's debt is 102% greater than its equity
CELU's equity has dropped by 82% year-on-year and by 74% since the previous quarter
CELU's debt is down by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.